Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Trastuzumab

TENDER DESCRIPTION

GWQ ServicePlus AG intends to conclude non-exclusive rebate agreements according to § 130a para. 8 SGB V for the above-mentioned active substance with contract start on 01.10.2026. All interested companies may join this contract at any time during the contract term on the same conditions (admission model). GWQ assumes that this procedure, due to the absence of a selection decision and thus the non-discriminatory access possibility for all pharmaceutical companies, does not fall under the scope of cartel procurement law. The contract documents, the participating health insurance funds and their turnover as well as the dates for the notification of the contract can be viewed and downloaded on the tender portal of GWQ ServicePlus AG at https://vergabeportal.gwq-serviceplus.de/arzneimittel. Until the start of exclusive contracts, this transitional agreement is open for accession by all market participants. If the signed contracts/declaration and proofs are received by 10.09.2026, an initial notification can be realized as of 01.10.2026. The following documents must be submitted: signed contract in duplicate or with qualified electronic signature (QES); proof of medicinal product…

TENDER BRIEF

TENDER DOCUMENTS